BILL ANALYSIS

HR6106

BEARISH

CLEAR Path Act

HR6106 (CLEAR Path Act) carries an AI-assessed market impact score of 5/10 with a bearish outlook for investors. This legislation directly affects Palantir ($PLTR) and Lockheed Martin ($LMT). The primary sectors impacted are Technology and Defense. View the full bill text on Congress.gov.

5/10

Impact Score

bearish

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR 6106 is a procedural early-stage bill with zero funding and minimal support — no near-term market impact.

The bill targets post-employment lobbying by Senate-confirmed officials, not company operations or federal spending.

If the bill somehow gained momentum, it would marginally increase compliance costs for defense contractors that hire former senior Pentagon officials.

How HR6106 Affects the Market

No real market impact. The CLEAR Path Act is legislative vaporware with a 1% chance of passage in its current form. Defense and technology investors should completely ignore this bill until it shows signs of committee action, which currently appears nonexistent. No ticker price movement can be attributed to this bill. Palantir ($PLTR), Lockheed ($LMT), and RTX are theoretically exposed to higher compliance costs in a hypothetical future where the bill passes, but that scenario is not remotely in play.

Bill Details

Metric	Value
Bill Number	HR6106
Impact Score	5/10Certainty: Committee hearing (+0.3 velocity (5 actions)) · Financial Magnitude: $60.0B — major funding · Strategic Weight: AI qualitative assessment: 1/10 · Market Penetration: 2 companies directly affected across 2 sectors
Market Sentiment	bearish
Event Date	November 18, 2025
Affected Sectors	Technology, Defense
Affected Stocks	Palantir ($PLTR), Lockheed Martin ($LMT)
Source	View on Congress.gov →

Summary

HR 6106 (CLEAR Path Act) is an early-stage bill in the 119th Congress with only 1 cosponsor, no committee markup, and zero allocated funding. It would extend post-employment conflict-of-interest restrictions for Senate-confirmed officials. The near-term market impact is effectively zero — the bill is dead unless it gains substantial momentum. No sector or stock is currently affected.

Full AI Market Analysis

1) On November 18, 2025, Representative Pfluger (R-TX) introduced HR 6106, the CLEAR Path Act, which amends 18 U.S.C. §207 to impose a 2-year ban on Senate-confirmed officials representing any person or entity before their former executive branch agency, and a lifetime ban on representing foreign governments. The bill was referred to three committees (Foreign Affairs, Judiciary, Rules) and has only 1 cosponsor (Rep. Crow, D-CO). There have been zero subsequent actions: no hearings, no markup, no votes. The bill sits on the legislative shelf. 2) The bill authorizes ZERO dollars. It is a purely regulatory measure — it imposes new restrictions on former government officials but creates no spending program, no tax credit, no procurement fund. Authorization vs. appropriation is irrelevant here because there is no funding to be authorized. 3) Structural winners: None. No company or sector receives any direct benefit from extended cooling-off periods. Structural losers: Defense and technology contractors that frequently hire former Senate-confirmed officials from DoD, State, and intelligence agencies — specifically prime contractors like Lockheed ($LMT), RTX, and Palantir ($PLTR). The restriction marginally increases the cost and friction of hiring senior government talent. However, the dollar impact is tiny relative to these companies' revenues (e.g., $LMT's annual revenue exceeds $60B). 4) No real market data is provided for these tickers. Based on structural positioning, the impact is negligible. 5) Timeline: The bill remains in the House with no scheduled hearings. Even if it were marked up, the 119th Congress has only one more full session year (2026) before the 2026 midterm elections reset the legislative agenda. With 1 cosponsor and no committee chair backing, passage probability is below 5%.